INJ Search


Regulation on Ethics

The Journal adheres to the ethical guidelines for research and publication described in Good Publication Practice Guidelines for Medical Journals ( and Guidelines on Good Publication (

1. Registration of Clinical Trial Research

Any research that deals with a clinical trial should be registered with a primary national clinical trial registration site such as, or other sites accredited by WHO or the International Committee of Medical Journal Editors.

2. Disclosure of Conflict of Interest

Conflict-of-Interest Statement
A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could bias the author's decisions of the manuscript. Authors are expected to provide detailed information about all relevant financial interests and relationships or financial conflicts, particularly those present at the time the research was conducted and through publication, as well as other financial interests (such as patent applications in preparation), that represent potential future financial gain. All disclosures of any potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript will be disclosed by the corresponding author on behalf of each coauthor, if any, as part of the submission process. Likewise, authors without conflicts of interest will be requested to state so as part of the submission process. If authors are uncertain about what constitutes a relevant financial interest or relationship, they should contact the editorial office. Failure to include this information in the manuscript will prohibit commencement of the review process of the manuscript. For all accepted manuscripts, each author's disclosures of conflicts of interest and relevant financial interests and affiliations and declarations of no such interests will be published. The policy requesting disclosure of conflicts of interest applies for all manuscript submissions. If an author's disclosure of potential conflicts of interest is determined to be inaccurate or incomplete after publication, a correction will be published to rectify the original published disclosure statement. Authors are also required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies as part of the submission process. For all accepted manuscripts, each author's source of funding will be published.
Funding/Support and Role of Sponsor
Authors are required to make clear of their contribution to their manuscript in cover letter. To be listed as an author one should have contributed substantially to all three categories established by the International Committee of Medical Journal Editors (ICMJE): (1) conception and design, or acquisition, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The ICMJE further states that acquisition of funding, the collection of data, or general supervision of the research group, by themselves, do not justify authorship. Individuals who have contributed substantially to some but not all of the three categories, or in other areas, should be listed in Acknowledgments. In principle, we do not allow the addition of authors or the changes of the first or the corresponding author after our initial decision to accept the manuscript for publication. Written causes of changing should be submitted when the authors of a manuscript is changed, approval of the Editorial board is needed when the first author or corresponding author is changed, and approval of the Chief Editor is needed when other authors is changed before acceptance of the submitted manuscript. If an author wishes to be removed from the byline, he or she should submit a signed letter indicating his or her wish to be deleted from the list of authors. The change in the order in the byline requires a letter from all authors indicating agreement with the same.

3. Examination on Ethics

Personal information with which a patient's identity can be established cannot be published with any forms including texts, photos, and pedigree. When personal information of patients is critical as scientific data, it should be stated clearly that the purpose of the study and mental and physical damages that can be done during the participation to the study were sufficiently explained for and written contents were submitted by the participants or their caregivers. In a report of an experiment for human subjects, it should be stated that the study was performed according to the Helsinki Declaration ( and approved by the Research Ethics Committee (REC) or the Institutional Review Board (IRB) of the institution where the experiment was performed. A written informed consent should be obtained from all subjects. The data for explanation such as photos should not include names, English initials, and hospital numbers of patients. In cases of animal experiments, it should be stated clearly that the processes complied with regulations of institutions or national research committee related to breeding and using laboratory animals or the NIH Guide for the Care and Use of Laboratory Animals. If necessary, it can be required to submit written consents and approvals of ethics committee.

4. Originality and Duplicate Publication

Manuscripts that have been already published elsewhere or in this journal should not be published. When a similar article has been already elsewhere or in this journal, its copy should be submitted with the relevant manuscript. The Editorial Board of the INJ will decide whether the relevant manuscript is duplicately published and examine whether it can be published in this Journal.
The Editorial Board of INJ strictly prohibits the following malpractices associated with publication. If one of the malpractices is prominently detected in a paper, the paper will be forcefully retracted by the committee.
The followings are:
Fabrication: Behavior dishonestly creating some records, being not in existence.
Falsification: Behaviors selectively modifying some data from a study or distortedly explaining uncertain things resulted from a statistical analysis of the study.
Plagiarism: Behaviors making a fraudulent use of others’ idea, method, results, and sentence etc. without an appropriate permission from them.
INJ will follow the guidelines by the Committee on Publication Ethics (COPE, for settlement of any misconduct.
INJ uses iThenticate (plagiarism screening tool) as a Similarity Check ( to detect instances of overlapping and similar text in submitting manuscripts. The Editorial Board of INJ will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check.

Journal Impact Factor 2.3
  • Regulation on Ethics
  • Best Practice
  • article_btn
  • Copyright transfer form / Conflict of Interest Statement / Author consent for use of PPT
  • Endnote Style File
  • Email Alert
  • Author's Index
  • E-Submission
Related society
Indexed By
Crossref Services
SCImago Journal & Country Rank

Article Category

Browse all articles >


Browse all articles >


Browse all articles >


Browse all articles >


Official Journal of Korean Continence Society & ESSIC (International Society for the Study of BPS) & Korean Society of Urological Research & The Korean Children’s Continence and Enuresis Society & The Korean Association of Urogenital Tract Infection and Inflammation & Korean Society of Geriatric Urological Care
Editorial Office
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine,
29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea
Tel: +82-2-2001-2237     Fax: +82-2-2001-2247    E-mail:

Copyright © 2024 by Korean Continence Society.

Developed in M2PI

Close layer
prev next